AP

APURES CO., LTD.

Biotech R&D using a miniature pig model, offering CRO services and biomaterials to pharma.

149300 | KO

Overview

Corporate Details

ISIN(s):
KR7149300006
LEI:
Country:
South Korea
Address:
경기도 평택시 청북읍 한산길 44, 평택시
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

APURES CO., LTD. is a biotechnology company that provides comprehensive R&D solutions for the pharmaceutical and life sciences industries. The company's core business is centered on its proprietary 'MICROPIG,' an internationally registered miniature pig model anatomically and physiologically similar to humans, which serves as a platform for advanced medical research. APURES offers a range of products and services, including standardized R&D resources (organs, tissues, primary cells), non-clinical Contract Research Organization (CRO) services for drug development, and bio-materials for regenerative medicine and xenotransplantation. Building on its expertise in transgenic models, the company is also strategically expanding into the development of proprietary gene therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 80.7 KB
2025-08-05 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 27.6 KB
2025-07-28 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 28.5 KB
2025-07-28 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 110.8 KB
2025-07-18 00:00
Major Shareholding Notification
[기재정정]임원ㆍ주요주주특정증권등소유상황보고서
Korean 33.6 KB
2025-07-18 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 27.8 KB
2025-07-10 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(약식)
Korean 104.6 KB
2025-07-10 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 28.6 KB
2025-07-02 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 28.6 KB
2025-06-24 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 91.3 KB
2025-06-24 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 28.7 KB
2025-06-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 91.3 KB
2025-06-16 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 28.7 KB
2025-06-12 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 104.4 KB
2025-06-09 00:00
Major Shareholding Notification
[기재정정]주식등의대량보유상황보고서(일반)
Korean 97.0 KB

Automate Your Workflow. Get a real-time feed of all APURES CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for APURES CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for APURES CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Qurient Co., Ltd. Logo
Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.
South Korea
115180
Rafael Holdings, Inc. Logo
Invests in and develops novel therapeutics for cancer and rare diseases.
United States of America
RFL
RaQualia Pharma Inc. Logo
An R&D firm discovering novel small molecules for out-licensing to pharma partners.
Japan
4579
Recruit Holdings Co., Ltd. Logo
Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.
Japan
6098
RELMADA THERAPEUTICS, INC. Logo
A clinical-stage biotech developing novel therapies for CNS diseases and oncology.
United States of America
RLMD
Renascience Inc. Logo
Develops innovative drugs and AI-powered medical devices for aging and hereditary diseases.
Japan
4889
Rentracks CO.,LTD. Logo
A pay-per-performance ad network with a closed ASP and comprehensive web consulting services.
Japan
6045
Replimune Group, Inc. Logo
Clinical-stage biotech developing oncolytic immunotherapies to treat a broad range of cancers.
United States of America
REPL
ReproCELL Incorporated Logo
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
Japan
4978
RESEARCH FRONTIERS INC Logo
Develops and licenses smart glass tech for instant light, UV, and heat control.
United States of America
REFR

Talk to a Data Expert

Have a question? We'll get back to you promptly.